Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

• Status: Completed
• Trial end date: 2018-01-30
• Target enrollment: 0
• Participant gender: All

Summary

Title Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin with or without Interferon among Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS) Study Design Endpoint Classification: Safety/Efficacy Study Intervention Model: Treatment agents (non-interventional observational study): Real life clinical practice study Masking: Open Label Primary Purpose: Treatment Duration Around 12 Months Study Centre Multi centric Study

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PharmEvo Pvt Ltd
• Treatments: Interferons; Ribavirin; Sofosbuvir

Criteria

Inclusion Criteria:

• Men and women, 18 years of age or older,

• Treatment -Naïve and not responded with the previous therapy

• Cirrhosis

• Not previously enrolled in any trial of Sofosbuvir

Exclusion Criteria:

• Not given informed consent

• Pregnancy